Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm A Martin

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Virology|June 1, 2012
Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studiesRajeev Gautam, Yoshiaki Nishimura, Wendy R Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 14, 2016
DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIVXintao Hu, Antonio Valentin, Frances Dayton, et al.
NPJ Vaccines|October 26, 2021
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitopeMorgan E Abernathy, Harry B Gristick, Jost Vielmetter, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaqueLaura M Walker, Devin Sok, Yoshiaki Nishimura, et al.
Nature Communications|February 9, 2022
Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimerZhi Yang, Kim-Marie A Dam, Michael D Bridges, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2012
Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strainsMasashi Shingai, Olivia K Donau, Stephen D Schmidt, et al.
Plos Pathogens|March 6, 2018
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infectionsKshitij Wagh, Michael S Seaman, Marshall Zingg, et al.
The Journal of Clinical Investigation|October 8, 2021
Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent stagingJoana Dias, Giulia Fabozzi, Kylie March, et al.
Cell Reports|August 13, 2025
Clonal expansion and diversification of germinal center and memory B cell responses to booster immunization in primatesLachlan P Deimel, Yoshiaki Nishimura, Gabriela S Silva Santos, et al.
Nature|April 28, 2016
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challengesRajeev Gautam, Yoshiaki Nishimura, Amarendra Pegu, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Virology|June 1, 2012
Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studiesRajeev Gautam, Yoshiaki Nishimura, Wendy R Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 14, 2016
DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIVXintao Hu, Antonio Valentin, Frances Dayton, et al.
NPJ Vaccines|October 26, 2021
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitopeMorgan E Abernathy, Harry B Gristick, Jost Vielmetter, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaqueLaura M Walker, Devin Sok, Yoshiaki Nishimura, et al.
Nature Communications|February 9, 2022
Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimerZhi Yang, Kim-Marie A Dam, Michael D Bridges, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2012
Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strainsMasashi Shingai, Olivia K Donau, Stephen D Schmidt, et al.
Plos Pathogens|March 6, 2018
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infectionsKshitij Wagh, Michael S Seaman, Marshall Zingg, et al.
The Journal of Clinical Investigation|October 8, 2021
Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent stagingJoana Dias, Giulia Fabozzi, Kylie March, et al.
Cell Reports|August 13, 2025
Clonal expansion and diversification of germinal center and memory B cell responses to booster immunization in primatesLachlan P Deimel, Yoshiaki Nishimura, Gabriela S Silva Santos, et al.
Nature|April 28, 2016
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challengesRajeev Gautam, Yoshiaki Nishimura, Amarendra Pegu, et al.
Pageof 7